Literature DB >> 9785337

Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?

A Osterborg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9785337

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  5 in total

Review 1.  Reticulocytes and reticulocyte enumeration.

Authors:  R S Riley; J M Ben-Ezra; R Goel; A Tidwell
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

Authors:  Jean-Luc Canon; Johan Vansteenkiste; Michael Hedenus; Pere Gascon; Carsten Bokemeyer; Heinz Ludwig; Jan Vermorken; Jason Legg; Beatriz Pujol; Ken Bridges
Journal:  Med Oncol       Date:  2011-11-13       Impact factor: 3.064

3.  Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.

Authors:  Massimo Martino; Esther Oliva; Giuseppe Console; Caterina Stelitano; Mohamed Fujo; Giuseppe Messina; Giuseppe Irrera; Giulia Pucci; Rosalba Mandaglio; Vincenzo Callea; Francesco Nobile; Pasquale Iacopino; Fortunato Morabito
Journal:  Support Care Cancer       Date:  2004-10-06       Impact factor: 3.603

4.  The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.

Authors:  Matti Aapro; Ivo Abraham; Carsten Bokemeyer; Heinz Ludwig; Karen Macdonald; Pierre Soubeyran; Matthew Turner
Journal:  Support Care Cancer       Date:  2007-09-14       Impact factor: 3.603

5.  Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.

Authors:  Pere Gascón; César A Rodríguez; Vicente Valentín; Jesús García Mata; Joan Carulla; Javier Cassinello; Ramón Colomer; Eva Baró
Journal:  Support Care Cancer       Date:  2013-06-22       Impact factor: 3.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.